DEBIGLIP M (Metformin (500mg) + Vildagliptin (50mg))

Debiglip-M Tablet is a formulation that combines two active ingredients aimed at managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. By effectively controlling blood sugar, this medication plays a vital role in preventing severe complications related to diabetes, including potential kidney impairment and vision loss, and may help lower the risk of heart attacks and strokes. It can be prescribed independently or in conjunction with other antidiabetic medications. The effectiveness of all diabetes treatments is maximized when accompanied by a balanced diet and consistent physical activity. The prescribed dosage will vary based on individual health conditions, current blood sugar readings, and any additional medications being taken. Consuming this medication alongside meals may mitigate the risk of gastrointestinal discomfort. Adherence to a regular dosing schedule, ideally at the same time each day, is crucial for optimal results, and it should not be discontinued without medical advice. Managing blood sugar levels is essential for preventing future complications, and maintaining a healthy lifestyle is imperative for controlling diabetes effectively. While using this medication, awareness of potential side effects, such as diarrhea, nausea, vomiting, headaches, and low blood sugar, is necessary, especially if you are on other diabetes treatments that may also lower blood sugar levels. Prior to beginning treatment, disclosing any history of kidney, liver, or heart disorders, pancreatic issues, or excessive alcohol consumption to your healthcare provider is essential for ensuring your safety. Pregnant or nursing individuals should seek medical guidance before starting this medication, as it may not be suitable for all patients.